News
ALKBH3 biomarker helps predict Hodgkin lymphoma aggressiveness
The absence of ALKBH3 allows cancer cells to grow more freely and is an indicator of malignancy for this type of tumors. The study, published in Blood, has the participation of IDIBELL, ICO and HUB, among others.
Identified the cellular process by which Cisplatin chemotherapy causes neuronal damage
Cisplatin induces senescence of peripheral neurons through overexpression of the p21 protein, which would explain the neuropathy
“What and how to eat during cancer” is released, a project of the Xarxa Audiovisual Local with the participation of IDIBELL
When a cancer is diagnosed, the patient asked many questions: about the treatment, his new daily rutine, his new life… And also about a new way of eating. A good diet is essential to guarantee a good nutritional state and to tolerate cancer treatments. Moreover, it is known that side effects contribute to malnutrition in […]
The AECC finances the implantation of a new cancer model in C. elegans
erón’s project proposes to use the nematode C. elegans to introduce into its genome cancer mutations from patients. Thus, have a low-cost animal model to obtain functional information on these mutations and explore therapeutic possibilities by testing drugs in these avatar worms with patient mutations.
Interferon, the key to many of the worst cases of COVID-19 in young people
An international consortium with the participation of IDIBELL has identified alterations in interferon and the proteins of its signaling pathway, the first line of defense against pathogens, as predictive markers of severity in individuals with no medical history.
IDIBELL participates in Sónar+D to take a trip to the musical brain
A trip into the musical brain: this was the artistic and scientific experience that the 2020 edition of the Sónar+D Festival offered this past Saturday, within a special program that combined the streaming and face-to-face formats from the Center for Contemporary Culture of Barcelona. Dr. Antoni Rodríguez Fornells, a researcher at IDIBELL, ICREA and the […]
Jordi Guiu, the new group leader of the Regenerative Medicine Program
Jordi Guiu joins to IDIBELL as group leader and opens the Cell Plasticity and Regeneration group of the Regenerative Medicine Program
Stand-up science has started preparing IDIBELL scientists to become a science YouTubers
Six scientists from IDIBELL have received training to perform a scientific monologue in live and to produce an informative video on YouTube.
IDIBELL’s sarcoma research group will receive one of the new grants of AECC Innova
The group led by Dr. Óscar Martínez-Tirado will receive 180,000 euros in two years to develop a new therapy for Ewing’s sarcoma.